nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—Haematochezia—Mesalazine—Crohn's disease	0.0446	0.0446	CcSEcCtD
Roflumilast—Pancreatitis acute—Mesalazine—Crohn's disease	0.0389	0.0389	CcSEcCtD
Roflumilast—Gamma-glutamyltransferase increased—Mesalazine—Crohn's disease	0.0219	0.0219	CcSEcCtD
Roflumilast—Pancreatitis acute—Prednisone—Crohn's disease	0.0206	0.0206	CcSEcCtD
Roflumilast—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.0175	0.0175	CcSEcCtD
Roflumilast—Immune system disorder—Mercaptopurine—Crohn's disease	0.015	0.015	CcSEcCtD
Roflumilast—Malnutrition—Mercaptopurine—Crohn's disease	0.0145	0.0145	CcSEcCtD
Roflumilast—Renal failure acute—Mesalazine—Crohn's disease	0.0141	0.0141	CcSEcCtD
Roflumilast—Atrial fibrillation—Mesalazine—Crohn's disease	0.0138	0.0138	CcSEcCtD
Roflumilast—Suicidal ideation—Prednisone—Crohn's disease	0.0136	0.0136	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.0122	0.0122	CcSEcCtD
Roflumilast—Gastritis—Mesalazine—Crohn's disease	0.0116	0.0116	CcSEcCtD
Roflumilast—Skin disorder—Mercaptopurine—Crohn's disease	0.0115	0.0115	CcSEcCtD
Roflumilast—Endocrine disorder—Prednisone—Crohn's disease	0.0115	0.0115	CcSEcCtD
Roflumilast—Influenza—Mesalazine—Crohn's disease	0.0113	0.0113	CcSEcCtD
Roflumilast—Pneumonia—Azathioprine—Crohn's disease	0.0111	0.0111	CcSEcCtD
Roflumilast—Infestation—Azathioprine—Crohn's disease	0.011	0.011	CcSEcCtD
Roflumilast—Infestation NOS—Azathioprine—Crohn's disease	0.011	0.011	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.0108	0.0108	CcSEcCtD
Roflumilast—Hepatobiliary disease—Azathioprine—Crohn's disease	0.0104	0.0104	CcSEcCtD
Roflumilast—Decreased appetite—Mercaptopurine—Crohn's disease	0.0103	0.0103	CcSEcCtD
Roflumilast—Weight decreased—Mesalazine—Crohn's disease	0.0102	0.0102	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.0102	0.0102	CcSEcCtD
Roflumilast—Pneumonia—Mesalazine—Crohn's disease	0.0101	0.0101	CcSEcCtD
Roflumilast—Infestation NOS—Mesalazine—Crohn's disease	0.0101	0.0101	CcSEcCtD
Roflumilast—Infestation—Mesalazine—Crohn's disease	0.0101	0.0101	CcSEcCtD
Roflumilast—Depression—Mesalazine—Crohn's disease	0.01	0.01	CcSEcCtD
Roflumilast—Urinary tract infection—Mesalazine—Crohn's disease	0.00978	0.00978	CcSEcCtD
Roflumilast—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00951	0.00951	CcSEcCtD
Roflumilast—Sinusitis—Mesalazine—Crohn's disease	0.00944	0.00944	CcSEcCtD
Roflumilast—Rhinitis—Mesalazine—Crohn's disease	0.00905	0.00905	CcSEcCtD
Roflumilast—Immune system disorder—Azathioprine—Crohn's disease	0.00895	0.00895	CcSEcCtD
Roflumilast—Mediastinal disorder—Azathioprine—Crohn's disease	0.00893	0.00893	CcSEcCtD
Roflumilast—Connective tissue disorder—Mesalazine—Crohn's disease	0.00887	0.00887	CcSEcCtD
Roflumilast—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00871	0.00871	CcSEcCtD
Roflumilast—Cardiac disorder—Mesalazine—Crohn's disease	0.00838	0.00838	CcSEcCtD
Roflumilast—Immune system disorder—Mesalazine—Crohn's disease	0.00816	0.00816	CcSEcCtD
Roflumilast—Mediastinal disorder—Mesalazine—Crohn's disease	0.00814	0.00814	CcSEcCtD
Roflumilast—Diarrhoea—Mercaptopurine—Crohn's disease	0.00809	0.00809	CcSEcCtD
Roflumilast—Ill-defined disorder—Azathioprine—Crohn's disease	0.00801	0.00801	CcSEcCtD
Roflumilast—Mental disorder—Mesalazine—Crohn's disease	0.00791	0.00791	CcSEcCtD
Roflumilast—Malaise—Azathioprine—Crohn's disease	0.00778	0.00778	CcSEcCtD
Roflumilast—Tension—Mesalazine—Crohn's disease	0.00771	0.00771	CcSEcCtD
Roflumilast—Dysgeusia—Mesalazine—Crohn's disease	0.0077	0.0077	CcSEcCtD
Roflumilast—Nervousness—Mesalazine—Crohn's disease	0.00763	0.00763	CcSEcCtD
Roflumilast—Back pain—Mesalazine—Crohn's disease	0.0076	0.0076	CcSEcCtD
Roflumilast—Muscle spasms—Mesalazine—Crohn's disease	0.00756	0.00756	CcSEcCtD
Roflumilast—Vomiting—Mercaptopurine—Crohn's disease	0.00752	0.00752	CcSEcCtD
Roflumilast—Rash—Mercaptopurine—Crohn's disease	0.00745	0.00745	CcSEcCtD
Roflumilast—Dermatitis—Mercaptopurine—Crohn's disease	0.00745	0.00745	CcSEcCtD
Roflumilast—Tremor—Mesalazine—Crohn's disease	0.00736	0.00736	CcSEcCtD
Roflumilast—Myalgia—Azathioprine—Crohn's disease	0.00735	0.00735	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.0073	0.0073	CcSEcCtD
Roflumilast—Ill-defined disorder—Mesalazine—Crohn's disease	0.00729	0.00729	CcSEcCtD
Roflumilast—Discomfort—Azathioprine—Crohn's disease	0.00726	0.00726	CcSEcCtD
Roflumilast—Angioedema—Mesalazine—Crohn's disease	0.00718	0.00718	CcSEcCtD
Roflumilast—Malaise—Mesalazine—Crohn's disease	0.00709	0.00709	CcSEcCtD
Roflumilast—Vertigo—Mesalazine—Crohn's disease	0.00706	0.00706	CcSEcCtD
Roflumilast—Nausea—Mercaptopurine—Crohn's disease	0.00702	0.00702	CcSEcCtD
Roflumilast—Infection—Azathioprine—Crohn's disease	0.007	0.007	CcSEcCtD
Roflumilast—Palpitations—Mesalazine—Crohn's disease	0.00695	0.00695	CcSEcCtD
Roflumilast—Skin disorder—Azathioprine—Crohn's disease	0.00684	0.00684	CcSEcCtD
Roflumilast—Myalgia—Mesalazine—Crohn's disease	0.00669	0.00669	CcSEcCtD
Roflumilast—Anxiety—Mesalazine—Crohn's disease	0.00667	0.00667	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00665	0.00665	CcSEcCtD
Roflumilast—Discomfort—Mesalazine—Crohn's disease	0.00661	0.00661	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00642	0.00642	CcSEcCtD
Roflumilast—Infection—Mesalazine—Crohn's disease	0.00637	0.00637	CcSEcCtD
Roflumilast—Nervous system disorder—Mesalazine—Crohn's disease	0.00629	0.00629	CcSEcCtD
Roflumilast—Skin disorder—Mesalazine—Crohn's disease	0.00623	0.00623	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00608	0.00608	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00584	0.00584	CcSEcCtD
Roflumilast—Feeling abnormal—Azathioprine—Crohn's disease	0.0058	0.0058	CcSEcCtD
Roflumilast—Insomnia—Mesalazine—Crohn's disease	0.0058	0.0058	CcSEcCtD
Roflumilast—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00576	0.00576	CcSEcCtD
Roflumilast—Dyspepsia—Mesalazine—Crohn's disease	0.00565	0.00565	CcSEcCtD
Roflumilast—Decreased appetite—Mesalazine—Crohn's disease	0.00558	0.00558	CcSEcCtD
Roflumilast—Abdominal pain—Azathioprine—Crohn's disease	0.00557	0.00557	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00554	0.00554	CcSEcCtD
Roflumilast—Fatigue—Mesalazine—Crohn's disease	0.00553	0.00553	CcSEcCtD
Roflumilast—Constipation—Mesalazine—Crohn's disease	0.00549	0.00549	CcSEcCtD
Roflumilast—Weight decreased—Prednisone—Crohn's disease	0.0054	0.0054	CcSEcCtD
Roflumilast—Depression—Prednisone—Crohn's disease	0.00531	0.00531	CcSEcCtD
Roflumilast—Feeling abnormal—Mesalazine—Crohn's disease	0.00529	0.00529	CcSEcCtD
Roflumilast—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00525	0.00525	CcSEcCtD
Roflumilast—Hypersensitivity—Azathioprine—Crohn's disease	0.00519	0.00519	CcSEcCtD
Roflumilast—Urticaria—Mesalazine—Crohn's disease	0.0051	0.0051	CcSEcCtD
Roflumilast—Abdominal pain—Mesalazine—Crohn's disease	0.00507	0.00507	CcSEcCtD
Roflumilast—Diarrhoea—Azathioprine—Crohn's disease	0.00482	0.00482	CcSEcCtD
Roflumilast—Hypersensitivity—Mesalazine—Crohn's disease	0.00473	0.00473	CcSEcCtD
Roflumilast—Connective tissue disorder—Prednisone—Crohn's disease	0.00469	0.00469	CcSEcCtD
Roflumilast—Dizziness—Azathioprine—Crohn's disease	0.00466	0.00466	CcSEcCtD
Roflumilast—Asthenia—Mesalazine—Crohn's disease	0.0046	0.0046	CcSEcCtD
Roflumilast—Vomiting—Azathioprine—Crohn's disease	0.00448	0.00448	CcSEcCtD
Roflumilast—Rash—Azathioprine—Crohn's disease	0.00444	0.00444	CcSEcCtD
Roflumilast—Dermatitis—Azathioprine—Crohn's disease	0.00444	0.00444	CcSEcCtD
Roflumilast—Headache—Azathioprine—Crohn's disease	0.00441	0.00441	CcSEcCtD
Roflumilast—Diarrhoea—Mesalazine—Crohn's disease	0.00439	0.00439	CcSEcCtD
Roflumilast—Immune system disorder—Prednisone—Crohn's disease	0.00431	0.00431	CcSEcCtD
Roflumilast—Dizziness—Mesalazine—Crohn's disease	0.00424	0.00424	CcSEcCtD
Roflumilast—Mental disorder—Prednisone—Crohn's disease	0.00419	0.00419	CcSEcCtD
Roflumilast—Nausea—Azathioprine—Crohn's disease	0.00418	0.00418	CcSEcCtD
Roflumilast—Malnutrition—Prednisone—Crohn's disease	0.00416	0.00416	CcSEcCtD
Roflumilast—Vomiting—Mesalazine—Crohn's disease	0.00408	0.00408	CcSEcCtD
Roflumilast—Rash—Mesalazine—Crohn's disease	0.00404	0.00404	CcSEcCtD
Roflumilast—Dermatitis—Mesalazine—Crohn's disease	0.00404	0.00404	CcSEcCtD
Roflumilast—Headache—Mesalazine—Crohn's disease	0.00402	0.00402	CcSEcCtD
Roflumilast—Ill-defined disorder—Prednisone—Crohn's disease	0.00386	0.00386	CcSEcCtD
Roflumilast—Nausea—Mesalazine—Crohn's disease	0.00381	0.00381	CcSEcCtD
Roflumilast—Angioedema—Prednisone—Crohn's disease	0.0038	0.0038	CcSEcCtD
Roflumilast—Malaise—Prednisone—Crohn's disease	0.00375	0.00375	CcSEcCtD
Roflumilast—Vertigo—Prednisone—Crohn's disease	0.00374	0.00374	CcSEcCtD
Roflumilast—Myalgia—Prednisone—Crohn's disease	0.00354	0.00354	CcSEcCtD
Roflumilast—Anxiety—Prednisone—Crohn's disease	0.00353	0.00353	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00352	0.00352	CcSEcCtD
Roflumilast—Discomfort—Prednisone—Crohn's disease	0.0035	0.0035	CcSEcCtD
Roflumilast—Infection—Prednisone—Crohn's disease	0.00337	0.00337	CcSEcCtD
Roflumilast—Nervous system disorder—Prednisone—Crohn's disease	0.00333	0.00333	CcSEcCtD
Roflumilast—Skin disorder—Prednisone—Crohn's disease	0.0033	0.0033	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00309	0.00309	CcSEcCtD
Roflumilast—Insomnia—Prednisone—Crohn's disease	0.00307	0.00307	CcSEcCtD
Roflumilast—Dyspepsia—Prednisone—Crohn's disease	0.00299	0.00299	CcSEcCtD
Roflumilast—Decreased appetite—Prednisone—Crohn's disease	0.00295	0.00295	CcSEcCtD
Roflumilast—Fatigue—Prednisone—Crohn's disease	0.00293	0.00293	CcSEcCtD
Roflumilast—Constipation—Prednisone—Crohn's disease	0.0029	0.0029	CcSEcCtD
Roflumilast—Feeling abnormal—Prednisone—Crohn's disease	0.0028	0.0028	CcSEcCtD
Roflumilast—Gastrointestinal pain—Prednisone—Crohn's disease	0.00278	0.00278	CcSEcCtD
Roflumilast—Urticaria—Prednisone—Crohn's disease	0.0027	0.0027	CcSEcCtD
Roflumilast—Abdominal pain—Prednisone—Crohn's disease	0.00268	0.00268	CcSEcCtD
Roflumilast—Hypersensitivity—Prednisone—Crohn's disease	0.0025	0.0025	CcSEcCtD
Roflumilast—Asthenia—Prednisone—Crohn's disease	0.00244	0.00244	CcSEcCtD
Roflumilast—Diarrhoea—Prednisone—Crohn's disease	0.00232	0.00232	CcSEcCtD
Roflumilast—Dizziness—Prednisone—Crohn's disease	0.00224	0.00224	CcSEcCtD
Roflumilast—Vomiting—Prednisone—Crohn's disease	0.00216	0.00216	CcSEcCtD
Roflumilast—Rash—Prednisone—Crohn's disease	0.00214	0.00214	CcSEcCtD
Roflumilast—Dermatitis—Prednisone—Crohn's disease	0.00214	0.00214	CcSEcCtD
Roflumilast—Headache—Prednisone—Crohn's disease	0.00213	0.00213	CcSEcCtD
Roflumilast—Nausea—Prednisone—Crohn's disease	0.00202	0.00202	CcSEcCtD
